-
Antibody-drug conjugates
Assessing the pharmacokinetics of antibody-drug conjugates (ADCs)
Pharmacokinetics (PK) and pharmacodynamics (PD) are two interdependent properties of ADCs. Together, they dictate the clinical outcomes of ADC therapies. For this reason, their thorough analysis during preclinical development…
-
CAR-T cell therapy
From the first to the fifth generation of CAR-T cells
Read more -
Antibody-drug conjugates
Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution
Read more -
CAR-T cell therapy
The structure of CAR-T cells
Read more -
Antibody-drug conjugates
ADC payloads
Read more -
Peptide synthesis
Challenges in chemical and recombinant peptide production processes
Read more
-
Antibody production
Overcoming the Hurdles of Antibody Production and Scale-Up
Read more -
Antibody production
How To Improve The Yield Of Your Antibody Production?
Read more -
Antibody production
How Can Single B Cell Sorting Propel Your Antibody Discovery to New Heights?
Read more -
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more -
Antibody production
Is Your Antibody Development Taking Too Long? Speed It Up with These Tips!
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Read more -
Antibody production
Reinventing IgY biotherapeutics
Read more -
Antibody production
How the environment shapes immune system development during pregnancy
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Read more